The antiinflammatory activity of IgG: the intravenous IgG paradox - Wikidata - wikimedia - TriplyDB

The antiinflammatory activity of IgG: the intravenous IgG paradox

The antiinflammatory activity of IgG: the intravenous IgG paradox

http://www.wikidata.org/entity/Q24676548

about

CD32B is highly expressed on clonal plasma cells from patients with systemic light-chain amyloidosis and provides a target for monoclonal antibody-based therapy Recent Progress towards Novel EV71 Anti-Therapeutics and Vaccines Fc receptors and their influence on efficacy of therapeutic antibodies for treatment of viral diseases B in TB: B Cells as Mediators of Clinically Relevant Immune Responses in Tuberculosis Inflammatory etiopathogenesis of systemic lupus erythematosus: an update Fc-fusion proteins and FcRn: structural insights for longer-lasting and more effective therapeutics Cross-presentation of IgG-containing immune complexes The Crystal Structure of CHIR-AB1: A Primordial Avian Classical Fc Receptor Structural Characterization of Anti-Inflammatory Immunoglobulin G Fc Proteins A pilot study showing differences in glycosylation patterns of IgG subclasses induced by pneumococcal, meningococcal, and two types of influenza vaccines.Different glycosylation pattern of human IgG1 and IgG3 antibodies isolated from transiently as well as permanently transfected cell lines.Prominent plasmacytosis following intravenous immunoglobulin correlates with clinical improvement in Guillain-Barré syndrome.IgG glycan hydrolysis by a bacterial enzyme as a therapy against autoimmune conditions.Recapitulation of IVIG anti-inflammatory activity with a recombinant IgG Fc.Macrophages activated by C-reactive protein through Fc gamma RI transfer suppression of immune thrombocytopenia.Efficacy and safety of Privigen, a novel liquid intravenous immunoglobulin formulation, in adolescent and adult patients with chronic immune thrombocytopenic purpura.Mechanisms of action of intravenous immunoglobulins.Fully recombinant IgG2a Fc multimers (stradomers) effectively treat collagen-induced arthritis and prevent idiopathic thrombocytopenic purpura in mice Plasmacytoid dendritic cells, interferon signaling, and FcγR contribute to pathogenesis and therapeutic response in childhood immune thrombocytopenia.Diagnosis and management of autoimmune cytopenias in childhood.Passively administered pooled human immunoglobulins exert IL-10 dependent anti-inflammatory effects that protect against fatal HSV encephalitis.Soluble immune complexes shift the TLR-induced cytokine production of distinct polarized human macrophage subsets towards IL-10 Regulation of immune responses by the neonatal fc receptor and its therapeutic implications The Role of Th17 in Neuroimmune Disorders: A Target for CAM Therapy. Part III Idiopathic transverse myelitis and neuromyelitis optica: clinical profiles, pathophysiology and therapeutic choices Emerging antibody products and Nicotiana manufacturing.Anti-aβ oligomer IgG and surface sialic acid in intravenous immunoglobulin: measurement and correlation with clinical outcomes in Alzheimer's disease treatment.The Effects of Antigen-Specific IgG1 Antibody for the Pulmonary-Hypertension-Phenotype and B Cells for Inflammation in Mice Exposed to Antigen and Fine Particles from Air Pollution.A serotype 3 pneumococcal capsular polysaccharide-specific monoclonal antibody requires Fcγ receptor III and macrophages to mediate protection against pneumococcal pneumonia in mice.Recombinant IgG2a Fc (M045) multimers effectively suppress experimental autoimmune myasthenia gravis.Antibody-mediated rejection in kidney transplantation: a review Major methylation alterations on the CpG markers of inflammatory immune associated genes after IVIG treatment in Kawasaki disease Intravenous immunoglobulin in the management of lupus nephritis.Enhanced control of Mycobacterium tuberculosis extrapulmonary dissemination in mice by an arabinomannan-protein conjugate vaccine.Immunity to the conserved influenza nucleoprotein reduces susceptibility to secondary bacterial infections Characterization and comparison of commercially available TNF receptor 2-Fc fusion protein products Autoimmune associated congenital heart block: integration of clinical and research clues in the management of the maternal / foetal dyad at risk.Bench-to-bedside review: Immunoglobulin therapy for sepsis - biological plausibility from a critical care perspective A new synthesis for antibody-mediated immunity.Identification of a receptor required for the anti-inflammatory activity of IVIG.

P2860

Q24649764-FC5691C2-EB77-4CCC-8FDB-6A5AACE7BF1B Q26775734-94590841-7D58-4437-897B-22800DA2B197 Q26783175-D39C6076-ADB5-470A-BAF5-D7D8B362EF5F Q26786655-DA739FDF-45BC-46A6-9E7B-97692810B9B3 Q26796413-021741E1-E9E9-4071-B2BE-0262C9965811 Q26822421-DE6F0802-C8A4-4B9A-9074-52D301959D1E Q26825801-9689C2C1-CC87-415F-9114-541158B10E19 Q27651190-68D736F0-9DB4-43BE-A4CB-6857B712CD3E Q27684721-7CCFA3B8-9478-4945-94B5-495F9DBC6A1D Q30368704-BF92A9A2-2D76-4573-9AFB-AA8163888006 Q30428210-4D1AB8DD-EE49-4962-ADC1-D5D9241012B7 Q33332176-DEEECD09-D501-4986-9F9C-29E69317F994 Q33378924-B760285E-3D23-454B-B3EC-5FC6C257CE1A Q33379309-322CDDE3-A052-4280-B7B6-7546A7C5CAF8 Q33382862-08EE423C-14DB-4F24-9E6B-22CB4D8294FD Q33385549-0318FC6E-47D7-4683-B2EB-875F97CBB4CF Q33389428-BC5EB138-F082-43AC-A474-7E9AF725D6C7 Q33402880-E921CA32-11E0-4549-AC62-448830E286E3 Q33409032-A8D9823A-FA7B-43BF-AEB7-45EFF2D3FE9D Q33411497-5F9A8238-69DD-4792-A5EE-84943636FB2B Q33926907-F11F9A7A-37D4-48FA-9B2F-39FBC30BB574 Q34259885-AAD0A650-7238-418F-BE82-DCD97F7C577B Q34818194-D520B8C9-8C6F-4FC9-98C0-71120AF6CED0 Q35116966-2BA01E6F-F1DA-4F6D-BC28-02A7DBCF2367 Q35151856-DEAE2704-95EB-4BA3-BE21-548265E7F76F Q35194874-D367138F-07AA-40EA-B189-966B02510E8B Q35590968-3DD491C5-48D3-4A0B-A0A5-80D9F63CDD25 Q35665034-C2DE047B-125E-454D-BBC8-F9134626FEC6 Q35867546-92C94F13-6719-4604-9D42-5B68E33465BC Q35899107-B3F04BB2-174E-4789-A04F-CECEDB5197F7 Q35915453-94475AB0-D843-4848-8607-F649D8C4482E Q36106176-CE94C31A-4996-46FB-A5FD-5C8DAE5D49C9 Q36302368-FF7508B9-C116-4401-8138-D6CE4B4628BD Q36302781-38F18D3F-2B0A-4979-902F-A90281E0A60B Q36374228-C104BADE-A7CE-488D-9C1C-65F7A6979209 Q36411858-472BD938-7832-45E3-808C-19D644B23CEE Q36551056-6D7FD83B-974A-4DD4-A9BF-36A9FCA14209 Q36646072-5DA30734-09AA-483F-A284-9869151DCC59 Q36660720-554CA6EC-584D-4FF2-B39C-072F9B523D85 Q37018736-A5AD61ED-CB4E-4188-AA2D-B883C421D8A9

P2860

The antiinflammatory activity of IgG: the intravenous IgG paradox

http://www.wikidata.org/entity/Q24676548

description

2007 nî lūn-bûn

@nan

2007 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2007 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

name

The antiinflammatory activity of IgG: the intravenous IgG paradox

@ast

The antiinflammatory activity of IgG: the intravenous IgG paradox

@en

The antiinflammatory activity of IgG: the intravenous IgG paradox

@nl

type

label

The antiinflammatory activity of IgG: the intravenous IgG paradox

@ast

The antiinflammatory activity of IgG: the intravenous IgG paradox

@en

The antiinflammatory activity of IgG: the intravenous IgG paradox

@nl

prefLabel

The antiinflammatory activity of IgG: the intravenous IgG paradox

@ast

The antiinflammatory activity of IgG: the intravenous IgG paradox

@en

The antiinflammatory activity of IgG: the intravenous IgG paradox

@nl

P1433

Q24676548-AC6F3F99-BE37-4038-A0CA-662FABAA731E

P1476

Q24676548-FFD302B1-8BF8-4B99-9514-28CC1E25E51B

P2093

Q24676548-1C4EAD67-9601-4878-9516-6563C63F9DCB

Q24676548-A2486D9F-3085-4AD1-BA2D-7845E2D3988D

P2860

Q24676548-03BEAEDB-6067-45BF-B183-BCAE59335B24

Q24676548-09C780D8-160F-4771-93BC-19B948080E7E

Q24676548-19BE2108-09D2-4044-8B06-6CBFC3E13905

Q24676548-1D99829F-41A8-4F4B-AA98-83625ECF8188

Q24676548-25B26525-A9B2-4290-AB7E-AE352614C32A

Q24676548-2D2E0795-A60C-4C89-92C1-5B2BC08EAB7F

Q24676548-2DD79BB2-DF6E-40C5-B29D-8A8ECA117AFB

Q24676548-34411E36-B300-417A-8914-795862124744

Q24676548-39B77BFB-9D76-4AC4-9225-F2A4920672E9

Q24676548-4D51012F-0D2E-4702-B4C1-6CD3A859EC96

P304

Q24676548-E924198A-0325-4BC2-A082-9CAB49959E25

P31

Q24676548-B355C237-3ECA-45B8-9BC4-66C6D5A6920D

Q24676548-BE057BAD-3960-4D9F-949C-5E44453D853F

Q24676548-ca0446dc-f933-49ed-b18e-f2529863f3e3

P3181

Q24676548-D5FFE8D6-8F33-4D74-BB53-9DC6C35ABBC1

P356

Q24676548-ED84B9F1-7B1A-4FD6-9BBC-FE9F8672D3B8

P407

Q24676548-0CDD0046-26F3-4A05-B206-9FFE518BFCDE

P433

Q24676548-F54E6745-9074-4221-8ED9-8CB9965869B9

P478

Q24676548-4560A4A0-69D0-4EDC-821C-FA81CE748D5E

P577

Q24676548-BC1F345E-DF73-46E6-AD5B-D1B9B3709933

P5875

Q24676548-2DDECD43-3EBF-4AC6-89C5-0B7923C52030

P698

Q24676548-2E055648-66B0-4D4E-AFE8-1252917FD803

P921

Q24676548-4C8466F3-6D56-4D53-B81E-2D242F9274D0

Q24676548-6A2147F4-F9A2-4305-A340-0BDE1735597C

P932

Q24676548-8FC808DD-C8B5-4D62-A45F-39C8283EE514

P3181

P356

P1433

Journal of Experimental Medicine

P1476

The antiinflammatory activity of IgG: the intravenous IgG paradox

@en

P2093

Falk Nimmerjahn

http://www.w3.org/2001/XMLSchema#string

Jeffrey V Ravetch

http://www.w3.org/2001/XMLSchema#string

P2860

Inhibitory Fc receptors modulate in vivo cytotoxicity against tumor targets

Fcgamma receptors: old friends and new family members

Fc receptors and their interactions with immunoglobulins

Immunoglobulin G-mediated inflammatory responses develop normally in complement-deficient mice

Anti-inflammatory activity of IVIG mediated through the inhibitory Fc receptor.

Effects of intravenous immunoglobulin on platelet count and antiplatelet antibody disposition in a rat model of immune thrombocytopenia.

IVIg-mediated amelioration of murine ITP via FcgammaRIIB is independent of SHIP1, SHP-1, and Btk activity.

Colony-stimulating factor-1-dependent macrophages are responsible for IVIG protection in antibody-induced autoimmune disease.

Intravenous immunoglobulin ameliorates ITP via activating Fc gamma receptors on dendritic cells.

High-dose intravenous gammaglobulin for idiopathic thrombocytopenic purpura in childhood.

P304

11-5

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

29564

http://www.w3.org/2001/XMLSchema#string

P356

10.1084/JEM.20061788

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

204

http://www.w3.org/2001/XMLSchema#string

P577

2007-01-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6574557

http://www.w3.org/2001/XMLSchema#string

P698

17227911

http://www.w3.org/2001/XMLSchema#string

P921

P932

2118416

http://www.w3.org/2001/XMLSchema#string